Livdelzi (seladelpar) is a medicine that can treat primary biliary cholangitis (PBC) by reducing the amount of bile in your body. It does this by signaling the body to stop making bile acid.

KETAMINE shows promise in managing levodopa-induced dyskinesia by disrupting abnormal brain activity and promoting lasting neuroplasticity, new research has shown. Levodopa-induced dyskinesia is a ...

A new clinical trial, sponsored by UCL and UCLH, aims to extend survival for some patients with cancer in the biliary tract by treating them with therapies specifically tailored to the genetic profile ...